ESRRA and cancer: Furthermore the receptor has been shown to promote tumorigenicity and angiogenesis in human carcinoma cells xenografted onto Nude mice ([15]–[17], reviewed in [18]), suggesting that inhibition of ERRα could be beneficial in cancer treatment [19].